A lot of (digital) ink tends to get spilled about how much businesses grow their revenues each quarter. But sometimes, like with InMode's (NASDAQ: INMD) second-quarter earnings, the most exciting figure isn't the top-line sales. 

Instead, there's a certain component of the company's revenue mix that has far bigger and even more positive implications for its future performance. So let's learn which metric I'm talking about and why it's important for anyone considering an investment.

InMode makes workstations that plastic surgeons and other clinical practitioners of medical aesthetics use to reshape figures, tone muscles, eliminate fat deposits, and remove unsightly hairs, among many other applications. Customers first buy a workstation for their clinic, then they also buy accessories and consumable products that are necessary to provide treatments to people. Many of the consumables are items like cannulas and treatment applicators intended for one-time use.

Continue reading

Source Fool.com